Results
Filtros
Trump marks 1 year of government with historic shift in medicinal cannabis
President advances in the medicinal agenda and targets elderly electorate with CBD in Medicare, but signs law that threatens hemp market
When discussing medical cannabis, Trump states: “I don’t want to, but many people need it”
Trump states he does not intend to use medical cannabis, but acknowledges that the substance can be an alternative to opioids and necessary for many patients.
Trump's Order Does Not Change Federal Scenario and Cannabis Continues Without Legalization in the US
Despite the executive order signed by Donald Trump, cannabis continues without federal legalization in the US, keeping the market dependent on state laws
Trump reclassifies cannabis in the USA and recognizes medicinal use at the federal level; Check out the analysis
Move from Schedule I to Schedule III could unlock research, ease fiscal obstacles, and impact state markets
Trump reclassifies cannabis and paves the way for CBD coverage by Medicare
Trump says he is considering changing the federal status of cannabis in the United States
U.S. President says he is considering the reclassification of cannabis, a measure that could impact research, the market, and federal cannabis policy
Cannabis Companies' Stocks Rise on Expectations of Regulatory Change in the US, Following Trump's Signal
Analysis indicates that Donald Trump is considering measures to ease federal rules, including possible cannabis reclassification
Trump redefines hemp market: between pharmaceutical regulation and federal revenue
Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control
Trump signs halt agreement to recriminalize hemp in the U.S.; measure to take effect after 365 days
New legislation redefines hemp and bans most broad-spectrum CBD products starting in 2026
Trump supports bill that restricts THC in hemp and divides the sector in the US
Proposal redefining limits and banning derivatives with total THC advances in the Senate with White House support
Trump praises cannabidiol for seniors and cannabis stocks soar
The former president's post about the benefits of hemp-derived CBD for seniors moved the cannabis market in the U.S.
Full legalization of cannabis gains momentum in the US and puts pressure on Trump
Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition
Trump considers reclassifying marijuana as lower-risk drug
The Trump administration is considering reclassifying marijuana as a lower-risk drug, a move that would facilitate research, investments, and tax deductions for the sector
Trump will not legalize marijuana, former White House press secretary says
Sean Spicer stated that federal cannabis legalization will not happen under the Trump administration, despite signs of support for specific reforms during the campaign
Trump Administration Unlikely to Reclassify Marijuana Soon, White House Says
Statement contradicts Trump's previous support for cannabis reform
Cannabis Industry Donates $2 Million to Trump Super PAC Before Reclassification Order
Financial contributions from major companies in the sector occurred months before the president's executive measure, aiming for a change in federal legislation
White House confirms: Trump to address cannabis reclassification this Thursday (18)
Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification
Colombian President Urges Trump to Legalize Cannabis, Betting on an International Regulatory Framework
Amid tensions with Trump, Gustavo Petro suggests drug policy change and cannabis exports
DEA Keeps Cannabis Reclassification Pending Despite Trump's Executive Order
Agency presents new report without a defined timeline, while experts warn that a change to Schedule III would have profound impacts on research and taxation, but not federal legalization
Cannabis Stocks Surge in North America After Potential Reclassification in the US
Statement attributed to Donald Trump about changing federal marijuana classification boosts shares of major companies in the sector